What is Utah Medical Products's net debt?

Utah Medical Products (UTMD) reported net debt of -$87.2M in Q1 2026.

What is the long-term trend for Utah Medical Products's net debt?

Over 5 years (2020 to 2025), Utah Medical Products's net debt has grown at a 10.8% compound annual growth rate (CAGR), from -$51.21M to -$85.47M.

What does net debt mean?

Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.

Utah Medical Products UTMD Net debt

Discontinued — last reported Q1 '26

Net debt at other companies

Cabot CorporationCBT

1.1×-0.3×

Travel + LeisureTNL

6×+1.6×

HES

Hess MidstreamHESM

3.1×-0.1×

Helen Of TroyHELE

4.8×+2.6×

CorMedixCRMD

-0.9×—

Hyster-Yale Materials Handling, Inc.HY

27.5×+26.1×

Other financials

Income statement

See full

Revenue$8.7M-10.2%

Gross profit$5.3M-4.6%

Operating income$2.6M-18.6%

Net income$2.6M-14.4%

EPS (diluted)$0.82-10.9%

Balance sheet

See full

Cash & equivalents$87.4M+4.9%

Total debt$210.0K—

Total equity$120.4M+2.8%

Total assets$124.4M+1.5%

Cash flow

See full

Operating cash flow$3.1M-30.4%

CapEx$130.0K-29.3%

Free cash flow$3.0M-30.4%

Valuation

See full

Market cap$219.63M+26.4%

Enterprise value$132.44M+42.5%

P/E20.3×+6.4×

P/S5.9×+1.4×

Profitability

See full

Gross margin57.9%-0.4pp

Operating margin28.8%-3.9pp

Net margin28.9%-4.1pp

FCF margin34.7%0.0pp

Returns & leverage

See full

Return on equity9.1%-1.4pp

Debt / equity0×—

Current ratio28.6×+6.3×

Where this comes from

Calculated from Utah Medical Products’s reported figures.

$210.0Ktotal debt−$87.4Mcash and equivalents=-$87.2M

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's net debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Utah Medical Products's net debt?: Utah Medical Products (UTMD) reported net debt of -$87.2M in Q1 2026.
What is the long-term trend for Utah Medical Products's net debt?: Over 5 years (2020 to 2025), Utah Medical Products's net debt has grown at a 10.8% compound annual growth rate (CAGR), from -$51.21M to -$85.47M.
What does net debt mean?: Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.